Dec 14

Valence Discovery Announces CA$10.9 Million for AI-Aided Drug Discovery

3 min read
Charles Mandel

Housed in Montréal’s renowned Mila artificial intelligence (AI) research institute, AI startup Valence Discovery recently came out of stealth mode earlier this year and announced $10.9 million CAD ($8.5 million USD) in funding.

The startup partners with leading pharmaceutical and biotech companies, using AI and machine learning to support their drug discovery efforts.

Co-founder Daniel Cohen said Valence is using next-generation AI methods to “build the world’s most powerful chemistry engine,” and compares formulating new drugs to solving a complicated Rubik’s Cube.

Open Article
Read More
Read More
Charles Mandel

Ready to Become

Let’s explore how Valence can
accelerate your drug discovery efforts

Let's Talk

Get in Touch

* Name
* Subject
* Email Address
* Message
Phone Number

Thank you for reaching out.
We will be in touch soon.

Oops! Something went wrong while submitting the form.